Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeted Health Dialogues for Individuals With Psychosis Spectrum Disorders

NCT07888894 is registered in ClinicalTrials.gov with Uppsala University as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07888894 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Targeted Health Dialogues for Individuals With Psychosis Spectrum Disorders
Lead sponsor
Uppsala University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 1, 2026
Completion date
December 1, 2030
Enrollment
60 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic syndrome, psychoses

Arms

As registered; 1 arm.

  • Targeted health dialogues ExperimentalTargeted Health Dialogues

    Targeted health dialogues will be implemented utilizing a visual tool, the "Health curve" (Hälsokurvan). The "Health curve" displays the individual health profile, which is derived from participants' responses to three health domains. The domains under investigation encompass Dietary patterns, Levels of physical activity, and aggregated Alcohol and tobacco use, as well as Psychosocial circumstances and Hereditary predispositions to diabetes and cardiovascular diseases. The "Health curve" has three colors, ranging from green to red, with red indicating high risk.

    The conversation will be conducted as a person-centred dialogue, focusing on the participant's own motivation and goals for lifestyle changes.

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Changes from baseline in Body Mass Index after 12 months From enrollment to the end of the sudy at 12 months

Lead sponsor's other trials

Uppsala University, most recent start first.

Similar trials

Same condition (Psychotic Disorders) and phase, most recent start first.